HRX 2022 Speakers | Heart Rhythm Society

HRX 2022 Speakers

Sana M. Al-Khatib, MD, MHS, FHRS, CCDS

HRX 2022 Producer: Sana M. Al-Khatib, MD, MHS, FHRS, CCDSDr. Al-Khatib is a tenured Professor of Medicine at Duke University Medical Center, a board-certified clinical electrophysiologist and an experienced clinical researcher in cardiac arrhythmias. Her clinical expertise is in sudden cardiac death prevention, ventricular arrhythmias, implantable cardiac devices, and atrial fibrillation. Her research expertise lies in the design and conduct of clinical trials, outcomes research, cost-effectiveness analyses, electronic clinical decision support, and use of big data. She has close to 350 publications in peer-reviewed journals.

Dr. Al-Khatib is a Senior Associate Editor for Circulation and is on the Editorial Board for Heart Rhythm, the Cardiovascular Digital Health Journal, Circulation Arrhythmia and Electrophysiology, JACC EP, and the Journal of Cardiovascular Electrophysiology. Dr. Al-Khatib currently serves on the Heart Rhythm Society Board of Trustees as the Secretary and Treasurer and previously served on the Board of Trustees from 2011 to 2016. She has also served on the Heart Rhythm Society Program Committee, Digital Health Committee, Health Policy Committee, and the Finance Committee. Dr. Al-Khatib chaired the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society on the Management of Ventricular Arrhythmias and the prevention of Sudden Cardiac Death. She is a co-Producer for HRS' HRX meeting.

Priya Abani

Priya AbaniPriya Abani brings more than 20 years of experience in building high-performing organizations, launching innovative products on a global scale, and leading cross-industry strategic alliances.

As AliveCor CEO, Priya is leading the drive to patient-centric remote cardiological care. Under Priya’s leadership, the company has built the largest AI-driven consumer subscription service in the world for cardiovascular care. AliveCor has put its technology in the hands of more than 1.5 million people in 40 countries around the world. Priya led the company’s recent growth into enterprise markets with reimbursed cardiac monitoring services for healthcare providers, partnerships with pharmaceutical companies and clinical research organizations for remote cardiac safety testing and is overseeing the development of a comprehensive condition management service offering for cardiology.

Prior to joining AliveCor, Priya served as the General Manager at Alexa Voice Service (AVS) at Amazon, where she was responsible for leading product, engineering, technical enablement, and developer experience teams and led the expansion of Alexa technology into partner products. Earlier in her career, Priya was a Senior Director of Customer Enablement and Solutions Integration at Intel.

Christine M. Albert, MD, MPH, FHRS

Christine M. Albert, MD, MPH, FHRSDr. Albert is a Professor of Cardiology and the founding Chair of the Department of Cardiology at Cedars-Sinai Medical Center. She is also the Lee and Harold Kapelovitz Distinguished Chair in Cardiology within the Smidt Heart Institute at Cedars-Sinai. Additionally, Dr. Albert is a Visiting Professor at Harvard Medical School and an Epidemiologist at Brigham and Women’s Hospital.

Dr. Albert received her MD from Harvard Medical School and MPH from the Harvard School of Public Health. She completed her Internal Medicine, Cardiology, and Cardiac Electrophysiology training at Massachusetts General Hospital in Boston.

Dr. Albert is currently the Principal Investigator on two NIH-sponsored R01s, and her research focuses on epidemiology, risk stratification, and prevention of sudden cardiac death and atrial fibrillation in large prospective cohort designs and in multi-center clinical studies; most notably, seminal contributions regarding the contribution of diet, lifestyle, and genetics to the burden of heart rhythm disorders. Dr. Albert serves on the editorial boards of Heart Rhythm & Circulation and is the Second Past President of the Heart Rhythm Society.

David E. Albert, MD

HRX 2022 Speaker: David AlbertDavid E. Albert, MD is a physician, inventor and serial entrepreneur who has developed medical technologies and products over the last 40 years, turning a number of those innovations into tech startups. He is a founder and Chief Medical Officer of AliveCor. His previous startups include Corazonix Corp (sold to Arrhythmia Research Technology) and Data Critical (sold to GE). He invented the AliveCor® Kardia™ in 2010 and it immediately became a global sensation via a four-minute YouTube Video in January 2011. Dr. Albert has 80 issued US patents. He has authored or co-authored over 100 scientific abstracts and publications principally in the Cardiology literature. Dr. Albert has lectured at universities and leading medical centers all over the world as well as being a regular faculty member at the major Cardiology Scientific Meetings (AHA, ACC, HRS, TCT). Dr. Albert graduated with Honors from Harvard College and from Duke University Medical School. Dr. Albert currently lives in Santa Monica with his wife. They have four children and two granddaughters.

James Allred MD, FACC

James Allred MD, FACCPracticing electrophysiologist and co-founder of CV Remote Solutions, Dr. Allred is passionate about remote monitoring and speaks internationally about the importance of remote patient care. Dr. Allred is an active clinician, industry partner, and entrepreneur. He is a national leader in Afib clinic design, cardiac device consulting, and EP quality improvement initiatives.

Zachi Itzhak Attia, MSEE, PhD

Zachi Itzhak Attia, MSEE, PhDAn AI researcher in Mayo Clinic Minnesota, developing AI-based medical screening tests for early detection of cardiac diseases. Three of these tests are currently in the FDA approval process under "breakthrough designation". As the co-director of AI in cardiology, Zachi directs a team of AI researchers, working side by side with cardiologists to find effective algorithms to help patients get the care they need, as quickly as possible. Zachi Received his BSc and MSc in Electrical engineering from Ben Gurion University in Israel and his Ph.D. in Bioinformatics and Computational Biology from the University of Minnesota.

Ardy Arianpour, MBA

Ardy Arianpour, MBAArdy Arianpour is CEO & Co-Founder of Seqster, the leading patient-centric SaaS healthcare technology company that enables organizations to drive efficient healthcare via comprehensive medical records (EHR), individual genomic profiles (DNA), and personal health device data. For the first time, users create their own matched, longitudinal health data profile across all of their US-based healthcare data sources through person-centric interoperability.

Ardy is a visionary health tech executive and serial entrepreneur in biotech and digital health. Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic tests as CCO of Pathway Genomics, and served as SVP of Ambry Genetics, which sold to Konica in 2017 for $1 Billion.

As a key player in the 2013 landmark SCOTUS decision scrapping gene patents, Ardy played an instrumental role in expanding genetic testing access with the launch of BRCA testing benefiting patients and family members across the country.

Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was a Medical, Marketing, and Media's (MM&M) Top 40 Healthcare Transformer and San Diego Business Journal 40 under 40.

Shanti Bansal, MD

Shanti Bansal MDDr. Bansal is the CEO of Octagos Health and also practicing electrophysiologist. Octagos Health is a digital health care company focusing on AI and EMR integration. Dr. Bansal did his undergraduate at Johns Hopkins University majoring in biomedical engineering and computer science. He went onto Yale New Haven Hospital for cardiology fellowship training.  He remains dedicated to the advancement of remote monitoring and healthcare technologies.

Bleron Baraliu

Bleron BaraliuCo-founder & CEO at Ninety One

Bleron is a mathematician and a former Wall Street executive who has been at the forefront of building innovative solutions for complex problems at top institutions (Citigroup, Barclays, ZAIS Group, State Street). Collaborating with brilliant minds in applied math, AI, and advanced technologies, Bleron and team built several trading systems that earned him the designation "Top 30 Under 30 Traders" in the world, while managing large investment/hedge fund portfolios in financial derivatives.

Convinced we have reached a singularity convergence between technology, mathematics, and medical science that shall propel digital healthcare, Bleron left Wall Street to join forces with his wife, Nora Gashi, an Interventional Cardiologist trained at Lenox Hill Hospital. Together, they created Ninety One - a company founded on the vision of fusing medical science with state-of-the-art technologies & AI in order to accelerate precision medicine. The company builds tools and applications that empower physicians and scientists to achieve highly accurate and precise conclusions on the basis of collective intelligence from big data. The first platform is a cloud-native application that automates and optimizes remote monitoring of CIEDs and wearables.

Bleron earned a BA in Math (Honors) and MA in Applied Math, both from Columbia University.  He serves on the Board of Kosova's Math Society, International Institute for Extraordinary Intelligence - ATOMI, the New York School of Science in Kosova, and He lives in New York with his wife and three kids, and is an activist for education, human rights, and justice.

Patricia Baran

Patricia BaranPatricia Baran is a Senior Vice President of Healthcare Americas, providing integrated digital cardiac solutions. She has more than 25 years of experience in the healthcare and technology industries, where she has led teams to create and bring to market high-impact offerings and solutions for providers, payers, and patients.

Prior to AliveCor, Patricia held leadership positions at Teladoc Health and Livongo, where she was instrumental in transforming the industry with Whole-person Chronic Care Management offerings for Diabetes, Diabetes Prevention, Hypertension, and Mental Health. She also held a variety of leadership roles at GE Healthcare and Cardinal Health, working closely with providers, health systems, and pharmacy benefit managers. Patricia started her career as a registered nurse and remains a dedicated and passionate advocate for transforming healthcare.

Sanjeev Bhavnani, MD, FACC

Sanjeev Bhavnani, MD, FACCDr. Sanjeev Bhavnani works in the Digital Health Center of Excellence (DHCoE) - Center for Devices and Radiologic Health (CDRH) at the U.S. Food and Drug Administration (FDA).

Joy Bhosai MD, MPH

Joy BhosaiJoy is inspired by innovations that address gaps in access to high-quality care. As an Entrepreneur-in-Residence at Duke, she is the co-founder/CEO of Pluto Health, a company focused on improving patient access and care through a health platform that bridges siloed real world data (RWD).

She previously served as Chief of Digital Health and Strategy for the Duke Clinical Research Institute. Through previous public health work in Africa and Asia, she developed innovations focused on improving access to health services that were used for clinical trials, which then lead to her founding ChatrHealth, a health tech organization dedicated to developing patient safety and communication tools deployed across both academic and private health system settings. She has also worked with Health 2.0, directing a program that paired large industry leaders with health tech startups.

Joy is an alumni of Pomona College, where she studied anthropology and neuroscience, and a previous Fulbright Scholar. She received a Masters of Public Health from Yale, focusing on global health management, an MD with distinction from UCSF, where she completed the global health pathways concentration, and completed the management and leadership residency program at Duke.

Chad Bonhomme, MD, MBA, CCDS

Chad Bonhomme, MD, MBA, CCDSChad Bonhomme, MD, MBA, CCDS is an electrophysiologist who has founded and grown two electrophysiology programs in Chicago and Indianapolis. Known throughout industry for innovation in the marriage of technology and clinical workflow, he has extensive experience in the scaling of technology for heart failure management, same-day discharge, nutrition, peri-procedural education, GUI/Visualization design, and mobile app development.

Dr. Bonhomme received a B.S. in Zoology from the University of Florida with emphasis on animal adaptation and survival strategies and also completed CV Disease fellowship at UF Shands Jax. He trained in Electrophysiology at Aurora St. Luke's in Milwaukee. In 2014 he received an MBA from Universiteit Maastricht after defending the masters thesis "Implantable Device Based Data Management Through Patient Engagement" at Handelshochschule Leipzig.

He is currently working with BIOTRONIK in Digitalization and M&A.

Erin Brodwin

Erin BrodwinErin is a health tech reporter with Axios Pro focusing on digital health technologies, venture capital, and Big Tech. She previously reported for The Boston Globe's STAT News, Business Insider, Newsweek, Popular Science and Scientific American.

Mark Burton

Mark BurtonMark Burton currently serves as the Vice President of Health Economics, Reimbursement and Evidence for Medtronic’s Cardiac Rhythm Management (CRM), Cardiac Ablation Solutions (CAS), Cardiovascular Diagnostics and Services (CDS), and Mechanical Circulator Systems (MCS) Operating Units. In his role, Mark leads a diverse team that is responsible for driving global market access for patients needing Medtronic’s life changing and lifesaving technology.

Mark joined Medtronic in July of 2003 and has held multiple positions across the organization in Healthcare Economics, Market Access, Strategic Pricing, and Marketing. During his career at Medtronic Mark has been recognized as a thought leader in value based healthcare, economic evidence generation, and market access strategies.

Mark received his Masters of Business Administration from the Carlson School of Business at the University of Minnesota and also earned a Bachelor of Arts from the University of Minnesota in Economics.

Omar Carter

Omar CarterOmar Carter is the founder of the Omar Carter Foundation, a nonprofit organization that teaches CPR/AED awareness and educates the community about sudden cardiac arrest. He serves on the foundation's board as Chairman and Executive Director. Omar's passion for CPR/AED training began when his own life was saved by bystander-CPR in 2013. Omar is a graduate of Appalachian State University, and the UCLA Anderson School of Management’s Diverse Leaders Program. Currently, he is pursuing a Master of Business of Administration at the McColl School of Business at Queens University of Charlotte. He is also a Senior Accountant at a Charlotte law firm.

Recently, ESPN released a documentary on Outside the Lines about Omar's sudden cardiac arrest survival story, his former basketball career, and his Foundation's impact on the community. As a former collegiate and professional basketball player, Omar is dedicated to paying it forward by volunteering and staying active in the Charlotte area. He is also a proud husband, and dog-dad.

Alan Cheng, MD

Alan ChengDr. Cheng is a part-time Associate Professor of Medicine at the Johns Hopkins University School of Medicine and is currently the Chief Medical Officer and the Global Vice President for Clinical Research and Clinical Operations for the Cardiac Rhythm Management group at Medtronic. He earned his MD degree from Yale Medical School and served as a house officer in internal medicine on the Osler Medical Service at The Johns Hopkins Hospital. He was the principal investigator of two NIH R01 grants, one focused on the metabolomics of sudden cardiac death and another using claims data to assess the relationship between atrial fibrillation burden and major cardiovascular events. He later completed his MBA from the Kellogg School of Management at Northwestern University. He has published numerous articles in cardiac electrophysiology and is recognized as a fellow of the Heart Rhythm Society, the American Heart Association, and the American College of Cardiology. 

Ki Chon, PhD

Ki Chon, PhDKi H. Chon received the B.S. degree in electrical engineering from the University of Connecticut, Storrs; the M.S. degree in biomedical engineering from the University of Iowa, Iowa City; and the M.S. degree in electrical engineering and the Ph.D. degree in biomedical engineering from the University of Southern California, Los Angeles. He spent three years as an NIH Post-Doctoral fellow at the Harvard-MIT Division of Health Science and Technology.

He is currently the John and Donna Krenicki Professor and Head of Biomedical Engineering at University of Connecticut, Storrs, CT. He is fellow of IEEE, National Academy of Inventors, International Academy of Medical and Biological Engineering, American Institute of Medical and Biological Engineering, and Asia-Pacific Artificial Intelligence Association.

Andrea Clark

Andrea ClarkSVP, Sales & Marketing, Rhythm Management Group

With a wealth of knowledge and experience, Andrea leads all sales efforts for Rhythm and she also oversees strategic planning and program development both for Rhythm and our customers. Though she trained as a clinical nurse, she began her career as a sales representative for Pfizer Pharmaceuticals and then went on to work in sales and business development for Medtronic.

Andrea then went to St. Jude Medical/Abbott where she worked for 10 years guiding their sales, business development, product launches, and program development/management, all within the cardiac implantable market.

Nikolaos Dagres, MD

Nikolaos Dagres, MDDr. Dagres is an interventional electrophysiologist at the Heart Center Leipzig in Germany. His research focus is sudden cardiac death and the conduction of randomized trials. He is co-leader of the PROFID project, international chief investigator of the PROFID trials aiming at a personalized decision making for primary prevention defibrillator implantation after myocardial infarction, coordinating investigator of the PVI-SHAM-AF randomized trial that compares pulmonary vein isolation with sham procedure for atrial fibrillation and deputy chair of the steering committee of the RESET-CRT randomized trial that compares CRT-D with CRT-P. He is chair of the research pillar of the European Heart Rhythm Association and Deputy Editor of the EP Europace journal. He is particularly interested in the application of digital solutions in modern medicine and the way that these will affect clinical practice.

Aarti S. Dalal, DO, FHRS, CEPS-P

Aarti S. Dalal, DODr. Dalal is the associate director of pediatric electrophysiology at Vanderbilt University in Nashville, Tennessee.

Tony Das, MD

Tony DasDr. Tony Das is a nationally recognized Interventional Cardiologist and Vascular Specialist who serves as the Regional Medical Director of Innovation, Strategy, Digital Health and Endovascular at The Heart Hospital Baylor, Plano, TX. He founded Connected Cardiovascular Care, the first cardiology practice in the US dedicated to a Digital First approach utilizing personalized remote physiologic monitoring. Dr. Das is a life-long strategy expert in healthcare.

A 25-year career experienced with a long history of development in Biotech, Life Sciences, Medical Device startups and Digital Health. He has been listed for over 15 years as Best Cardiologists in Dallas by D. Magazine, Best Cardiologists in Texas by Texas Monthly magazine and Best Cardiologists in the US by Castle Connoly and Who's Who in Medicine and is proud to be the personal cardiologist of President George W. Bush. Dr. Das is an active member of the American College of Cardiology (ACC) committee for Innovation in the Wearables and Devices Section. Additionally, Dr. Das is a founding member of the the VIVA meeting and serves as consultant to several medical device startups and venture funds.

Currently, Dr. Das advises Med Tech Venture funds in the Healthcare Medical Device and Digital Health space with combined management of over $1B. Dr. Das graduated from Baylor Medical School, did his medical residency at Harvard Massachusetts General Hospital and Fellowship at the Texas Heart Institute. Dr. Das completed the Stanford Business School: LEAD Corporate Innovation Program 2020 and the MIT School of Business Blockchain Program in 2022.

Elizabeth Davenport, BA, RN, MSN, CNML

Beth Davenport, BA, MSN, RNElizabeth Davenport, BA,RN,MSN, CNML, serves as Director of Cardiology Services & Virtual Care at Atrium Health's Sanger Heart & Vascular Institute, in Charlotte, NC. Her professional nursing experience of more than 25 years includes critical care, cardiovascular recovery, cardiac rehabilitation, healthcare informatics and cardiac device management.

Elizabeth has presented at Heart Rhythm Scientific Sessions, South Atlantic Society of Electrophysiology for Allied Professionals, Medtronic's Paceart University and with the SHVI Center of Excellence on the role of remote monitoring and the management of patients with CIEDs. She currently serves on the HRS 2022-2023 Program Committee and the HRS Allied Professional Council. Elizabeth strives to improve both patient and clinician healthcare experiences by leveraging technology and creating innovative partnerships.

Mark J. Day

Mark DayMark J. Day serves as iRhythm's Chief Technology Officer and was formerly the Executive Vice President of Research & Development. He has had other leadership roles in Research & Development and systems development since joining in 2007.

Previously he worked in Medtronic's Cardiac Rhythm Disease Management division. Prior to that, Mr. Day was Chief Technical Officer of CarePages, Inc., a blogging site for patients.

Mr. Day has an M.B.A. in Marketing from the Wharton School, University of Pennsylvania, a Ph.D. in Computation Flow Physics from Stanford University, and also received an M.S. from Stanford, and a B.Sc. from Queen’s University, both in Mechanical Engineering.

Brynn E. Dechert-Crooks, APN, FHRS, CCDS

Brynn E. Dechert-Crooks, APN, FHRS, CCDSBrynn Dechert-Crooks is a pediatric electrophysiology nurse practitioner at the University of Michigan Congenital Heart Center with over 17 years of clinical EP experience.

Brynn is a certified pediatric nurse practitioner and IBHRE cardiac device specialist-allied professional. In addition to her clinical role, she is the manager of the pediatric cardiology advanced practice team. She regularly publishes original research in the field of pediatric electrophysiology with specific interest in CIED research

Thomas Deering, MD

Thomas Deering, MD Dr. Deering is a cardiac electrophysiologist at Piedmont Heart Institute in Atlanta where he serves as Chief of the Arrhythmia Center, Chief Quality Officer and Chair of the Cardiovascular Governance Center for Piedmont Healthcare. He has served in a variety of volunteer roles for the Heart Rhythm Society, most recently as president between May 2018 and May 2019. His research and clinical interests are focused on implementing quality/value initiatives in electrophysiology and cardiovascular medicine. He has served as a speaker and moderator at national and international electrophysiology and cardiology meetings; has authored and co-authored numerous publications addressing cardiac arrhythmia and cardiovascular quality issues; participates in a number of cardiac electrophysiology arrhythmia research projects and serves as a reviewer for multiple cardiac electrophysiology and general cardiac journals.

Dr. Deering earned his medical degree from Yale University School of Medicine. He completed his residency at the Yale-New Haven Hospital, his cardiac electrophysiology fellowship at Tufts New England Medical Center. He has previously been a Clinical Assistant Professor of Medicine at Yale University School of Medicine and at present is a Clinical Associate Professor of Medicine at the Medical College of Georgia and the Mark E. Silverman, M.D. Educational Chair.

Aneesh Deoras, MSE

Aneesh DeorasAneesh Deoras is the Assistant Director for Cardiac Ablation, Mapping, and Imaging Devices in FDA's Office of Cardiovascular Devices, Center for Device and Radiological Health.

Sumbul Desai, MD

Sumbul Desai, MDSumbul Desai, MD serves as Vice President of Health at Apple, overseeing health initiatives including clinical product development, medical research, and innovative clinical partnerships. She also leads the regulatory and quality teams at Apple. Apple is also working with the best in the medical field, including Harvard T.H. Chan School of Public Health, the American Heart Association, Brigham and Women's Hospital and Johns Hopkins University, to conduct landmark health studies and advance discovery with the ResearchKit and CareKit platforms. Apple recently launched its Health Sharing and Walking Steadiness features, adding to the many consumer health tools available on Apple Watch and iPhone including ECG, Irregular Heart Rhythm, Cycle Tracking and Hearing Health.

Dr. Desai recently served as Vice Chair of Strategy and Innovation in the Department of Medicine at Stanford Medicine, as well as Associate Chief Medical Officer at Stanford Healthcare. She also serves as Clinical Associate Professor in the Department of Medicine at Stanford School of Medicine.

Jodi Euerle Eddy

Jodi EddyJodi Euerle Eddy is Senior Vice President of Information Technology and Chief Information and Digital Officer for Boston Scientific Corporation, and a member of the Executive Committee. She is responsible for leading several departments, including Global Business Services, Enterprise IT and Commercial IT, in addition to leading a cross functional Global Digital Enablement Team to oversee the Boston Scientific digital strategy and key programs. She also is responsible for overseeing the company's strategy for digital health, data analytics and cybersecurity capabilities.

Eddy has been with Boston Scientific since 2013. Before joining Boston Scientific, Eddy progressed through several roles of increasing leadership responsibility. Eddy has more than 25 years of experience leading global teams and developing large-scale strategies and programs to make digital a competitive advantage.

Prior to Boston Scientific, Eddy spent 18 years working for General Electric (GE) where she served as the Commercial CIO for a $20 billion division of GE. Eddy holds a honorary Doctorate and a B.S. in Computer Science from Southern Connecticut State University and has multiple certifications in her field.

Utibe R. Essien, MD, MPH

Utibe R. Essien, MD, MPHUtibe R. Essien, MD, MPH is a board-certified internal medicine physician and health equity researcher at the University of Pittsburgh. Dr. Essien's research focuses on improving access to novel, evidence-based medications and technologies in the management of cardiovascular diseases. He has coined the term pharmacoequity to describe his research program and has extended his health equity framework to the COVID-19 pandemic, rapidly becoming an expert in examining the disparities that disproportionately affect minority communities with COVID-19.

Dr. Essien's work has been featured in leading medical journals including JAMA and the NEJM and he has been interviewed by several national news outlets including the New York Times, Washington Post, and NPR. Dr. Essien has also received nearly $2 million in research funding from the National Institutes of Health, the Dept. of Veterans Affairs, the American Heart Association, and the Robert Wood Johnson Foundation.

Dr. Essien is a fierce advocate for diversity and equity in medicine and his leadership in advancing health equity led him to receive several national awards including the 2019 National Minority Quality Forum 40 under 40 Leaders in Minority Health Award, one of Medscape's 20 Top Black Physician Social Media Influencers in 2020, and the AAMC Herbert Nickens Faculty Fellowship Award in 2021.

Tony Faranesh, PhD

HRX 2022 Speaker: Tony FaraneshTony is a research scientist with a focus on using consumer technologies to empower people to manage and improve their health. At Fitbit and Google, Tony leads algorithm development and clinical studies using wearables for disease screening and monitoring. Tony led the Fitbit Heart Study, the clinical trial for the Fitbit Irregular Rhythm Notifications feature, designed to detect signs of atrial fibrillation from the optical heart rate sensors on Fitbit devices.

Tony obtained his Ph.D. in Biomedical Engineering from Johns Hopkins University and did a post doctoral fellowship at Stanford University in the department of Radiology. He has spent much of his career in cardiovascular MRI research. Before joining Fitbit, Tony was a research scientist at the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, in Bethesda, Maryland.

Martha G. Ferrara, DNP, FNP, FHRS, CCDS

Martha G. Ferrara, DNP, FNP, FHRS, CCDSMartha G. Ferrara, DNP, FNP, FHRS, CCDS and currently Assistant Director of EP Services at White Plains Hospital, NY.

A nurse for over 40 years, patient care advocate, dedicated to health care education to empower patients for better health outcomes.

David Feygin, PhD, MBA

David Feygin, PhD, MBADavid Feygin is a digital and data healthcare executive with extensive experience in corporate, strategy, product, and commercial healthcare leadership and a deep background in transformative technology. Through two decades of expanding healthcare industry leadership, David has guided startups and enterprises, led organizations to enhance patient care on a global scale, and built digital technology solutions and innovative businesses that have saved lives.

Through a progressive tenure with Boston Scientific, David defined and ultimately led the enterprise digital and data efforts as Chief Digital Health & Data Officer and VP, Digital Health & Data Solutions. David established a growth-focused culture, innovated digital and data capabilities, created agile, iterative, lean, and user-focused development teams; and drove the enterprise toward digitalization. Prior, through evolving Director- and VP-level roles at Becton Dickinson, David led enterprise strategic innovation efforts, established a Corporate Product Security Office, led structured multiple startup investments, and created an Information-Enabled Medication Management strategy that laid the foundation for the transformational acquisition of CareFusion. Early in his career, David led the design, development, and global commercialization of a suite of Virtual Reality Medical Simulators for Laerdal Medical (formerly SimQuest).

David holds an MBA from Harvard University; a PhD in Mechanical Engineering from University of California, Berkeley; and a bachelor's degree in Mechanical Engineering from The Cooper Union for the Advancement of Science and Art.

A thought leader and influencer in his space, David works with industry shaping institutions, including MDIC Digital Health, Sheba Medical Center Future of Health Community, and is the Chair of the Executive Council of Brigham and Women’s Center for Patient Safety Research and Practice.

Tony Fiola

Tony FiolaTony Fiola is the Vice President & General Manager of the global Cardiac Diagnostics & Services (CDx) franchise for Boston Scientific, where he is responsible for BSC’s implantable cardiac monitor (ICM) & ambulatory electrocardiogram (AECG) portfolios, as well as the company’s ongoing work in the consumer wearables space.

He joined Boston Scientific from Eli Lilly & Company in 2003 and has held multiple leadership positions within Sales, Marketing and Commercial Operations before moving into his current role.

Laurent Fiorina, MD

HRX 2022 Speaker Laurent Fiorina Cardiologist and Electrophysiologist certificated and trained in the best Parisian Hospitals and in Canada, Dr. Laurent Fiorina practices in the Institut Cardiovasculaire Paris Sud which is at the forefront of innovations in the treatment of cardiovascular diseases. Passionate about innovation and digital solutions for cardiology, he was one of the first to see the potential of the Cardiologs technology applied to ECG.

Cardiologs is a medical technology company committed to transforming cardiac diagnostics using medical-grade artificial intelligence and cloud technology. As Cardiologs' medical expert, in collaboration with the engineering and data scientist team, Dr. Fiorina was part of the creation of the Cardiologs solution, assuring it be pertinent and adequate to Physicians' needs.

Peter J. Fitzgerald, MD, PhD, FACC

Peter J. Fitzgerald, MD, PhD, FACCDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University Medical School. He is an Interventional Cardiologist and has a PhD in Engineering. He is Emeritus Professor in both the Departments of Medicine and Engineering (by courtesy) at Stanford. Presently, Dr. Fitzgerald's laboratory includes 12 postdoctoral fellows and graduate engineering students focusing on state-of-the- art technologies in Cardiovascular Medicine. He has led or participated in over 175 clinical trials, published over 650 manuscripts/chapters, and lectures worldwide. He has trained over 150 post-docs in Engineering and Medicine in the past decade. In addition, he heads the Stanford/Taiwan MedTech innovation program.

Peter has been principle/founder of twenty-four medical device companies in the San Francisco Bay Area. Eighteen of these have gone public or transitioned to large healthcare/consumer companies. He serves on several boards of directors, advised dozens of medical device startups as well as multinational healthcare companies in the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Peter was on the founding team of LVP Capital, a venture firm, focused on medical device and biotechnology start-ups in San Francisco. In 2010, he co-founded Triventures in Israel, which is a venture fund focused on early-mid stage medical technology and digital healthcare.

Paul Friedman, MD, FHRS

Paul Friedman, MDDr. Paul Friedman is a Professor of Medicine and the Norman Blane & Billie Jean Harty Chair, Mayo Clinic Department of Cardiovascular Medicine Honoring Robert L. Frye, M.D. at Mayo Clinic, Rochester, Minnesota. He has served as Director of the Cardiac Implantable Device Lab, Mayo Clinic. He is a trained electrical engineer, with deep experience in innovation (> 60 patents issued, named Minnesota Top Inventor, founder of device and AI-based med tech companies), and scientific research (> 500 scientific original publications). He is a committed educator, serving as a director for 5 national and international meetings, editor of 7 textbooks, and author of over 60 book chapters. He is a frequent visiting professor and lecturer at educational meetings. His clinical practice includes implantation of cardiac devices, extraction, complex ablation and left atrial appendage occlusion. His research interests include testing and development of novel devices and new AI tools in medicine.

Dr. Friedman received his BA in Plan II liberal arts and BS in Electrical Engineering from the University of Texas at Austin. He received his medical degree from Stanford University and trained in internal medicine at the University of Washington, Seattle (internship) and Stanford University. He trained in cardiovascular medicine and cardiac electrophysiology at Mayo Clinic, Rochester, MN.

Sonja Fulmer, PhD

HRX 2022 Speaker: Sonja FulmerSonja Fulmer is Acting Deputy Director for the Digital Health Center of Excellence in the Center for Devices and Radiological Health (CDRH). In her permanent role of Assistant Director for Digital Health Policy, Dr. Fulmer works to help advance and implement new policy approaches to medical device software and digital health technologies to better promote and protect public health. Dr. Fulmer joined the Center for Devices and Radiological Health (CDRH) in 2014 as an AIMBE Scholar to pursue her interest in science policy after earning her undergraduate degree in Chemistry, with a Biochemistry concentration, from the University of Alabama at Birmingham (UAB) and her doctorate in Chemical and Physical Biology from Vanderbilt University.  Dr. Fulmer has held several policy-focused positions in the Office of the Center Director and later as a Policy Advisor in the Office of Policy at CDRH, before joining the Digital Health Center of Excellence.

Leonard Ganz, MD

Leonard Ganz, MDLeonard Ganz, M.D. joined Abbott in March, 2022 as Division Vice-President, Medical Affairs, and Chief Medical Officer, Cardiac Rhythm Management. Prior to this, he had a long career in clinical cardiac electrophysiology, practicing in academic, private practice, and community hospital settings.

Dr. Ganz trained in Internal Medicine, Cardiology, and Cardiac Electrophysiology at Brigham and Women’s Hospital and Harvard Medical School. He is board certified (ABIM) in Cardiovascular Diseases and Clinical Cardiac Electrophysiology. After completing his training, Dr. Ganz was an attending physician at Brigham and Women’s Hospital and Allegheny General Hospital. Later, he was Director of Cardiac Electrophysiology at the University of Pittsburgh Medical Center (UPMC). 

Dr. Ganz has served as a Trustee, Officer, and Chair of the Education Committee at Heart Rhythm Society. He has published and lectured extensively; medical device cybersecurity has been a recent area of interest. Dr. Ganz has been a prolific author and section editor for numerous topics relating to device and arrhythmia therapy in UpToDate. He has written the chapter on electrocardiography for multiple editions of Goldman’s Cecil Medicine textbook.

Dan Gebremedhin, MD

Dan Gebremedhin, MDDan Gebremedhin, MD is a Partner at Flare Capital Partners and serves on the Board of Flare portfolio companies Somatus, Eden Health, Oui Health, Vita/Vytyl Health, Votive Health and Elektra Health.

Prior to joining Flare Capital, Dan served as a Medical Director at the Harvard Pilgrim Health Plan. Dan spent over 8 years as a practicing Internal Medicine Physician on the Faculty of the Massachusetts General Hospital and Instructor in Medicine at Harvard Medical School, after completing Internal Medicine Residency at the Massachusetts General Hospital in 2010. Dan served on Massachusetts Governor Charlie Baker's Board of Nursing Home Administrators from 2016 to 2020. He has served as a Senior Health Policy Advisor for the Campaigns of Governor Charlie Baker, Congressman Joseph Kennedy III and Congressman Jake Auchincloss. Dan earned a B.S. from the University of California, San Diego, an M.D. from the Morehouse School of Medicine, and an M.B.A. from the Harvard Business School.

Dr. Hamid Ghanbari, MD

Dr. Hamid Ghanbari, MDDr. Ghanbari is an Assistant Professor of Medicine, Vice Chair of Innovation and Clinical Cardiac Electrophysiologist at University of Michigan. In his role as the vice chair of innovation, he oversees the Aikens Innovation Program that aims to harvest, develop and commercialize product and strategy innovations within the field of cardiovascular medicine. Dr. Ghanbari's research interests include digital health, machine learning and wearable sensors for detection and prediction of cardiovascular outcomes. His research is supported by national institutes of health and Toyota corporation. He is currently the deputy editor of cardiovascular digital health journal and the host of the cardiovascular digital health journal.

Thompson Godfrey

Thompson GodfreyThompson Godfrey is Director of Product at Rhythm Management Group.  Prior to joining Rhythm, Thompson spent 15 years in the CRM industry working at Boston Scientific and BIOTRONIK in a variety of roles from product management to sales leadership.  He is passionate about finding solutions that solve problems for customers and create value in the market. 

Paul Grand

Paul GrandPaul Grand is an investor and the founder and CEO of MedTech Innovator, the largest accelerator of medical technology in the world. The global nonprofit seeks to improve human health by accelerating the growth of startups and scaleups poised to transform healthcare.

Prior to MedTech Innovator, Paul was a serial entrepreneur starting companies in the biopharma, medtech, and tech industries. He became a venture capitalist in 2005, when he joined RCT Ventures, an early-stage life science investor where he served as Managing Director. At RCT, Paul focused on medtech investments and sourcing innovation. He founded MedTech Innovator as a program within RCT Ventures in 2013 and left to run MedTech Innovator as a stand-alone company with RCT's support in 2016.

Paul has interacted with thousands of medical technology startups as part of MedTech Innovator's rigorous review process to identify the most promising early-stage companies in the world. 509 companies are now in MedTech Innovator's portfolio, collectively bringing 155 products to market with a combined total of over $4.6B in follow-on funding.

Tarek Haddad

Tarek HaddadTarek Haddad is a Technical Fellow and Director of the Machine Learning and Statistics Group within Cardiac Implantables, Research & Technology at Medtronic. His team's area of focus is the development of machine learning/AI algorithms and stochastic models for improving patient outcomes, efficiencies in Patient Management, and user experience for both patients and health care providers, as well as improving the efficiency of clinical trial through innovative designs and methods.

At Medtronic Tarek is helping to set the vision for AI, and developed the knowledge, talent, and Hardware/software infrastructure needed to develop and deploy advanced AI algorithms into Medtronic's business. He specializes in Machine learning with a focus in Deep learning, signal processing, Bayesian modeling, and statistical methods, and has numerous publications and patents in these areas. He chaired the Medical Device Innovation Consortium working group on "clinical trials informed by simulation and bench".

He holds a MS in Biostatistics and a BA in Mathematics both from the University of Minnesota and has a Master Black Belt in Design for Six Sigma & Design for Reliability and Manufacturing.

Shouvik Haldar, MBBS MD(Res) FRCP, FESC, FACC

Shouvik Haldar, MBBS MD(Res) FRCP FESC FACCA Consultant Cardiologist and Electrophysiologist at the Royal Brompton and Harefield Hospitals in London, UK. I have a specialist interest in atrial fibrillation and real world applications of digital innovation in cardiology and am passionate about spreading excellent medical education so that patients can receive the highest quality of care from their medical team.

Janet Han, MD, FACC, FHRS

Janet Han, MD, FACC, FHRSDr. Janet K. Han is an Associate Professor of Medicine in the Cardiac Arrhythmia Center at the University of California, Los Angeles and VA Greater Los Angeles Healthcare System (VAGLAHS). She is a practicing interventional cardiac electrophysiologist and the director of the Cardiac Arrhythmia Digital Health Program at VAGLAHS, working closely with the Nation VA Office of Connected Care & the VA Innovations Ecosystem.

She is member of the inaugural ACC Digital Transformation Committee, Vice-Chair of the Heart Rhythm Society Communications committee, and is the current social media editor for JACC: Clinical Cardiac Electrophysiology. Her research interests in electrophysiology include digital health, health techquity & virtual care, CIEDs, arrhythmia management and prevention, and anticoagulation in special populations.

Curt Harper

Curt HarperAs the lead architect of PaceMate LIVE, Curt works toward bridging the gap between physicians and software developers. His background as a biomedical engineer, project manager at Epic Systems as well as Technical Service Specialist with Abbott offers him unique insight into the interplay between clinicians, EMR and software development.

At PaceMate, he manages ongoing research with numerous hospital systems. He has served as Director of Product Development and currently serves as Director of Business Development & Strategic Partnerships.

David Hayes, MD

David Hayes, MDDr. David Hayes received his Bachelor's degree in Biology and Doctorate of Medicine, with distinction, from the University of Missouri in Kansas City, Missouri. He completed his Internship and Residency in Internal Medicine, and his Residency in Cardiovascular Disease, at the Mayo Graduate School of Medicine in Rochester, Minnesota. He also completed training in cardiac pacing at Montefiore Medical Center in New York, and a Traveling Fellowship at the Surgical Clinic Val d'Or in Saint Cloud, France. He is a past Chair of the Cardiovascular Division, Mayo Clinic, Rochester, Minnesota, overseeing approximately 140 staff cardiologists and 700+ allied personnel. He is also a past president of HRS.

He currently serves as Chief Medical Officer, BIOTRONIK Inc.

Matthew Hazelett

HRX 2022 Speaker - Matthew Hazelett Matthew Hazelett started at the Food and Drug Administration as a biomedical engineer within the Implantable Electrophysiology Devices Branch (IEDB) at the Center for Devices and Radiological Health (CDRH). His review areas included pacemakers, defibrillators, leads, and supporting devices (programmers, home monitors, etc.). Since starting at FDA, he developed a review focus in cybersecurity, participates in cybersecurity guidance development, and supports cybersecurity vulnerability assessments and premarket reviews across CDRH. He started his position as the Cybersecurity Policy Analyst in the Office of Product Evaluation and Quality (OPEQ) in February 2020. His role is focused on premarket and postmarket cybersecurity policy development and implementation across the clinical review offices. He also serves as a Digital Health Center of Excellence Program Director for the OPEQ Cybersecurity Focal Point Program.

Matthew earned a B.S. in biomedical engineering from the University of Rochester where he focused in electrical signals and systems. After graduation, he worked for a medical device research and development company in New Hampshire as a Test Engineer and then Test Manager overseeing device verification and validation testing.

Ricardo Henao, PhD

Ricardo HenaoRicardo Henao, a quantitative scientist, is an Associate Professor in the department of Biostatistics and Bioinformatics at Duke University. He is also affiliated with the Department of Electrical and Computer Engineering (ECE), the Information Initiative at Duke (iiD), Duke AI Health and the Duke Clinical Research Institute (DCRI), all at Duke University.

The theme of his research is the development of novel statistical methods and machine learning algorithms primarily based on probabilistic modeling. His expertise covers several fields including applied statistics, signal processing, pattern recognition and machine learning. His methods research focuses on hierarchical or multilayer probabilistic models to describe complex data, such as that characterized by high-dimensions, multiple modalities, more variables than observations, noisy measurements, missing values, time-series, multiple modalities, etc., in terms of low-dimensional representations for the purposes of hypothesis generation and improved predictive modeling. Most of his applied work is dedicated to the analysis of biological data such as gene expression, medical imaging, clinical narrative, and electronic health records.

His recent work has been focused on the development of sophisticated machine learning models, including deep learning approaches, for the analysis and interpretation of clinical and biological data with applications to predictive modeling for diverse clinical outcomes.

Adrian Hernandez, MD, MHS

Adrian Hernandez, MD, MHSAdrian Hernandez, MD, MHS, is Executive Director, Duke Clinical Research Institute, and Vice Dean of the Duke University School of Medicine. Dr. Hernandez received his medical degree from the University of Texas-Southwestern Medical Center in Dallas. He completed his residency training in internal medicine at the University of California in San Francisco. Dr. Hernandez completed his fellowship in cardiology at Duke University Medical Center Cardiology in Durham, NC, as well as his MHS.

Dr. Hernandez has research interests in improving cardiovascular health and accelerating clinical evidence through outcomes research, clinical trials, comparative effectiveness and health policy. He had led multiple large-scale patient-centered research programs, registries and clinical trials aimed at improving health across multiple conditions such as NIH's Health System Collaboratory and PCORI's PCORnet resulting in more than 700 peer-reviewed publications.

Tripp Higgins

Tripp HigginsCEO + Co-Founder, PaceMate™

Tripp Higgins is the CEO and co-founder of PaceMate™, selected as one of the Top 100 Healthcare Technology Companies in the United States by Healthcare Technology Report. With a passion for entrepreneurs, Tripp serves as an investor and advisor to multiple startups in the healthcare and fintech spaces. After a career in surgical robotics and minimally invasive surgical procedures, he co-founded biocynetic™ in 2015, a software company aimed at eliminating the burden of gathering and analyzing disparate data sources to treat AFib, heart failure, and other types of chronic diseases.

An innovator in disruptive digital health technologies, Tripp used his expertise in the commercialization of medical devices to form the genesis of his vision for PaceMate and its industry-leading cardiac rhythm data and remote patient monitoring platform, PaceMateLIVE. Named as PaceMate’s CEO in 2019, Higgins has been instrumental in helping PaceMateLIVE to become one of the most widely adopted RPMs and the preferred choice of electrophysiologists, cardiac device clinics, and healthcare systems across the United States.

Actively involved in education and community development, Tripp helped co-found a Montessori school in Sarasota, Florida. Tripp is a former NCAA Division 1 athlete and graduate of the University of Memphis.

Mellanie True Hills, CSP

Mellanie True HillsMellanie True Hills, CSP is an atrial fibrillation patient (16+ years afib-free), non-profit CEO, internationally-known author, Certified Speaking Professional (CSP), and a passionate advocate for patients. She is the founder and Chief Executive Officer of the American Foundation for Women’s Health and, a global atrial fibrillation patient advocacy organization. Through, the most visited heart arrhythmia site worldwide, she seeks to raise awareness of atrial fibrillation, wipe out afib-related strokes, improve the quality of life of those living with afib, and enhance communication with health-care providers.

Successes include creating Atrial Fibrillation Awareness Month and lobbying with other organizations to gain U.S. Senate designation of September as National Atrial Fibrillation Awareness Month. She brings the voice of the atrial fibrillation patient community to guidelines, think tanks, health policy discussions, and awareness-raising coalitions and partnerships worldwide. Mellanie co-chaired the global Sign Against Stroke in Atrial Fibrillation Task Force, co-created with the American Heart Association, served on the Patient-Centered Outcomes Research Institute’s PCORnet Patient Council, convened the National AF Health Policy Roundtable, and hosts the annual Get in Rhythm. Stay in Rhythm.® Atrial Fibrillation Patient Conference.

She speaks at medical conferences and corporate events worldwide, is the author of three best-selling and multiple award-winning books, including A Woman’s Guide to Saving Her Own Life, and is one of just three non-profit CEOs worldwide to hold the highly-prestigious Certified Speaking Professional (CSP) designation from the National Speakers Association.

Gerhard Hindricks, MD, PhD

Gerhard Hindricks, MD, PhDDr. Gerhard Hindricks is a Professor of Medicine / Cardiology and the Medical Director of the Heart Center Leipzig. He is the Director of the Department of Electrophysiology of the Heart Center and the General Manager of the Leipzig Heart Institute (LHI). Gerhard Hindricks has a longstanding involvement in innovations and the development and clinical implementation of new technologies in the field of cardiovascular medicine and beyond. He has fundamental interest in design and implementation of novel process and diagnostic/therapeutic pathways in medicine. Moreover, Gerhard is Principal Investigator of multiple international, randomized and potentially guideline-relevant clinical trials.

He has served the European Society of Cardiology in several leadership functions including President of European Heart Rhythm Association and is member of the ESC Digital Committee. He is the Chairman of the 2020 Guidelines of the ESC for the management of atrial fibrillation. In addition, Gerhard Hindricks is the Chair of the ESC Task Force "Evolution of Cardiovascular Medicine, Training and Education". Overall, he has published almost 800 peer-reviewed articles in the leading journals of the world and is the Editor-in-Chief of the Europace Journal, one of the top international journals in the field of cardiac arrhythmias.

Kevin Hoffman

Kevin HoffmanThirty years ago, my mother survived cardiac arrest, she was 44 years old. The implanted defibrillator malfunctioned and shocked her inappropriately more than 100 times. Her experience was my motivation to work in the cardiac device industry and the impetus for the creation of Vector Remote Care.

I attended Arrhythmia Technologies Institute and worked in the field with St. Jude Medical for 15 years. Beginning in 2012, more cardiac devices began transmitting wirelessly. The cardiac digital revolution started and quickly became the standard of care.

I believe a thoughtful approach embraces technology to engage patients in their care and unlock cross-functional insights for physicians to transform cardiac disease management from reactive to personalized, precise care.

Jon Hunt

Jon HuntJon has over 34 years’ experience in the Medical/Medical Device Industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. Diverse executive experience in Fortune 500 companies as well as start-ups. Four successful exits and one IPO in the last 20 years: Cardiac Pathways, Cameron Health, Cryterion Medical (all acquired by Boston Scientific), Bardy Diagnostics (acquired by Hillrom) and HeartBeam, Inc. (IPO November 2021).

Jon is currently the EVP & Chief Business Officer of HeartBeam, Inc., serves as Chairman of the Board of AtriAN Medical Ltd., and advisor to other Founders of medical device and biotech start-ups.

Jodie L. Hurwitz, MD, FHRS

Jodie L. Hurwitz, MD, FHRSDr. Hurwitz is the Director of Electrophysiology at North Texas Heart Center and the Director of the Electrophysiology Lab at Medical City Heart and Spine Hospital in Dallas. She is President of the North Texas Electrophysiology Society and has been involved in multiple Heart Rhythm Society activities, including the Women's Leadership Initiative, serving as the HRS representative for the American Medical Association, and chairing the Membership Committee. She is also a member with the ABIM CCEP writing committee.

She received her medical degree from Albert Einstein College of New York and her Fellowship in Cardiology and Electrophysiology at Duke University Medical Center. Dr. Hurwitz is published widely and participates extensively in clinical and device trials, and has been named several times to the Best Doctors in Dallas and Texas Super Doctors.

Chris Irving

Chris IrvingChris Irving is Co-Founder and Chief Experience Officer at Murj, the leading platform for comprehensive cardiac device management. Based in Santa Cruz, California, Murj delivers next-generation cardiac device workflow software and solutions that empower users to manage their cardiac device patients with transformative productivity and insight. Founded in 2015, Murj is a rapidly growing company with more than 185 healthcare provider customers that use Murj to manage in excess of 350,000 cardiac device patients.

Hailing from Santa Cruz, Irving was a pre-med student at the University of California, Santa Barbara before discovering a passion for the internet. At the age of 26, he founded his first company, a web design firm focused on functional user-centered design, a precursor to modern user experience (UX). Irving has over 27 years of UX experience working for enterprises like Google and Yahoo!.

Irving specializes in bringing clarity to complexity. He oversees product design at Murj and draws on his love of medicine and innovation, as well as his passion for problem-solving, to make Murj the go-to platform for managing biomedical data to help both patients and clinicians alike.

Rodolphe Katra, PhD, MBA

Rodolphe Katra, PhD, MBADr. Katra is a Sr. Distinguished Scientist and a Technical Fellow at Medtronic. He works in the Research & Technology group where he leads novel initiatives and disruptive innovations for the Cardiac Rhythm Businesses.  With over 20 years of technical leadership and industry experience in the field, Dr. Katra is a thought leader in digital health, data management solutions, and analytics in cardiology. He leverages AI/ML, DSP, predictive analytics, and technology platforms to advance the field of personalized arrhythmia identification, contextual arrhythmia monitoring, chronic disease management, patient monitoring, and predictive analytics, using implantable and wearable medical devices.

Dr. Katra holds a Master's and Doctorate degrees in Biomedical Engineering and an MBA with an emphasis in Medical Industry. He has authored dozens of peer-reviewed publications and is a named inventor on over 50 issued patents in the areas of cardiac electrophysiology, personalized pathophysiology detection, prediction, monitoring, and disease management.

Robert Kazmierski, PhD

Robert KazmierskiRobert is a reviewer for cardiovascular devices at FDA. He has been with FDA for 8 years, reviewing implantable electrophysiology devices as well as diagnostic devices for FDA. He is currently Team Lead for Blood Pressure and Flow Devices Team within the Office of Cardiovascular Devices where digital health is playing an ever increasing role in the diagnosis of cardiovascular diseases and conditions.

Robert Kowal MD, PhD

Robert Kowal MD, PhDDr. Robert Kowal serves as the Chief Medical Officer, VP of Medical Affairs, Business Development & Strategy within the Cardiac Rhythm Management and Diagnostic Services businesses. In these roles, he is helping guide a patient-focused approach toward portfolio development, driving both organic development and inorganic acquisitions. He additionally supports medical safety for these arrhythmia businesses. Rob oversaw the medical education function from 2018-2020 and was CMO for the Cardiac Ablation Solutions business from 2018-2022.

Prior to Medtronic, Rob practiced electrophysiologist at Baylor Heart and Vascular Hospital and was Co-Medical Director of Electrophysiology for the Baylor Scott and White System and Best Care/Clinical Integration for the BSWH Quality Alliance. In those roles, he developed quality metrics and protocols for improving care and reducing unnecessary costs to patients. He was active in clinical research and on the Board of Managers at Baylor Heart and Vascular Hospital and the Board of Trustees for the Heart Rhythm Society until accepting his role at Medtronic.

Dr. Kowal received his undergraduate degree at Yale University and his MD and PhD degrees from UT Southwestern Medical Center, completing his doctorate work in molecule genetics with Drs. Michael Brown and Joseph Goldstein. He completed an internal medicine internship and residency as well as cardiovascular disease fellowship at Brigham and Women’s Hospital and then postdoctoral research and clinical cardiac electrophysiology fellowship at UT Southwestern where he went on to join the faculty as an Assistant Professor of Medicine for four years prior to transitioning his practice to the Baylor Healthcare system.

Fred M. Kusumoto, MD, FHRS

Fred KusumotoFred Kusumoto is Professor of Medicine, Associate Dean of Faculty Affairs at Mayo Clinic Florida. His research beyond clinical electrophysiology includes work on health policy, innovation, artificial intelligence, and communication in medicine. He is the immediate past president of the Heart Rhythm Society and past Governor of the Florida Chapter of the American College of Cardiology.

Jennifer Lavelle

JenniferLavelleAs head of Global Business Marketing for Philips Ambulatory, Monitoring and Diagnostics, Jennifer Lavelle brings over 20 years of healthcare expertise to drive the transformation of care to become more decentralized and virtual by connecting data across the patient ecosystem. Shifting care from in the hospital to anywhere, episodic to continuous, reactive to proactive, condition specific to holistic.

Jennifer is passionate about problem-solving and advocating to address and improve critical topics in healthcare specifically around social determinants of health and healthy aging.

Jennifer holds an MBA in Marketing and Managing Human Capital from Saint Joseph’s University and a Bachelor of Science in Business Administration from Bucknell University.

Harish Lecamwasam, MD

Harish Lecamwasam, MDHarish Lecamwasam is a senior healthcare executive with extensive experience leading companies in digital health and clinical services delivery from early stage through acquisition. He currently serves as the Chief Innovation Officer at Talis Clinical (acquired by Getinge) and is also an Assistant Professor in the Department of Anesthesia at the Warren Alpert Medical School of Brown University.

Harish earned his MD from the Harvard-MIT Division of Health Sciences and Technology after completing his graduate training in Biomedical Engineering at MIT. He is board certified in both anesthesia and critical care, and also has fellowship training in cardiac anesthesia.

Robert Lerman, MD

Robert Lerman, MDRob Lerman, MD is a senior physician executive and Chief Medical Officer of PrepMD RMS. Dr. Lerman received his BS from Stanford University and his medical degree from Albany Medical College. Returning to his native Los Angeles, he completed an internal medicine residency at Cedars-Sinai Medical Center, followed by fellowships in cardiology and clinical cardiac electrophysiology at Harbor-UCLA Medical Center and Good Samaritan Hospital in Los Angeles.

Dr. Lerman was the Medical Director of Cardiac Electrophysiology at St. Bernardine Medical Center in Southern California for 14 years and served as a Clinical Assistant Professor of Medicine at the David Geffen UCLA School of Medicine. He was an investigator in multiple clinical trials of ICD therapy and was an early adopter of CIED remote monitoring.

In 2012 Dr. Lerman joined Dignity Health as corporate VP of Physician Integration. Over the next six years he led new programs in both Clinical Integration and Clinical Supply Chain for one of the nation’s largest health systems as part of a growing focus on value-based care.

In 2018, Dr. Lerman joined LindaCare as their first Chief Medical Officer and VP of Clinical Operations. In this role, he led the LindaCare’s remote CIED clinical monitoring program and provided clinical and business direction for the software roadmap and defined feature requirements for the platform. Dr. Lerman is a member of the Heart Rhythm Society Interoperability Working Group. He joined PrepMD RMS in July 2022.

Chan Ho Lim

Chan Ho LimMachine Learning Engineer at Tulane TRIAD (Tulane Research Innovation for Arrhythmia Discovery).

Christopher Longhurst, MD, MS

Christopher Longhurst MDChristopher Longhurst MD, MS, is the chief medical officer (CMO) and chief digital officer (CDO) at UC San Diego Health. This dual, complementary role provides leadership to medical staff, ensuring that standards and protocols are in place to provide the highest quality of care to patients. He also serves as an associate dean at the School of Medicine, overseeing and aligning our education and research missions within the clinical environment, and leading our journey to become a highly reliable, learning health system.

As CMO, Dr. Longhurst is responsible for maintaining excellence in clinical care, including regulatory, patient and clinician satisfaction, quality and safety, and medical affairs. He works alongside leaders at UC San Diego Health, the School of Medicine, and UC Health to improve care delivery and oversees UC San Diego Health’s reputation for delivering safe, innovative, patient-centered care.

Dr. Longhurst is passionate about implementing innovative digital solutions that help improve the patient experience. As the CDO, he leads UC San Diego Health’s technology strategy, overseeing initiatives that advance the infrastructure across UC San Diego and the UC Health system. In addition, Dr. Longhurst leads the clinical activities of the academic medical center, working alongside clinical leaders to guide the planning of quality, safety, and performance excellence of programs.

He is also a key faculty member in the Departments of Biomedical Informatics and Pediatrics in the UC San Diego School of Medicine, maintaining an active clinical practice as a newborn hospitalist and pursuing scholarship in care quality, patient safety, and health informatics.

Prior to his current role, Dr. Longhurst served as the chief information officer (2015-2021) and associate chief medical officer for quality and safety (2018-2021) at UC San Diego Health, where he provided leadership in key functional areas to continuously improve efforts around operations, reputation and care.

Before joining UC San Diego Health, Dr. Longhurst served as chief medical information officer for Stanford Children's Health. He led strategic efforts to improve children's health and provider workflow using information technology. He founded and led the nation's first accredited clinical informatics fellowship at Stanford, where he was a clinical professor of pediatrics and biomedical informatics. He also staffed the quality committee of Stanford's hospital board and facilitated national quality improvement collaborative work.

Dr. Longhurst completed his residency at Stanford University and earned his medical degree and MS in medical informatics from UC Davis. He holds a BS in molecular biology from Revelle College at UC San Diego. He is a board-certified pediatrician and clinical informaticist.

He is the author and co-author of many publications on using technology and data to improve quality of care. Dr. Longhurst is an elected fellow of the prestigious American College of Medical Informatics.

Greg Madden

Greg MaddenGreg brings over 18 years of healthcare transaction experience to SV, including deep private and public healthcare company investment experience. Greg joined SV in 2002 as an Analyst and later transitioned to the role of Portfolio Manager with both portfolio and lead fundraising responsibilities. Following business school, Greg was promoted to Principal and became Partner in 2018. He was promoted again to Managing Partner in 2020. Greg is focused on medical device and healthcare services investments and is actively engaged in the financing, strategy, operations and acquisitions of portfolio companies.

Prior to SV, Greg worked at Testa, Hurwitz & Thibeault, in the Business Practice, Emerging Technology and Private Equity groups, supporting both venture capital funds and venture backed companies in business formations and financings, mergers and acquisitions, and venture capital fundraising. Academic Credentials BA, Honors, Colby College; MBA, Honors, Boston University (graduating Beta Gamma Sigma).

William H. Maisel, MD, MPH

William H. Maisel, MD, MPHWilliam H. Maisel, MD, MPH is Director of the Office of Product Evaluation and Quality and Chief Medical Officer at FDA's Center for Devices and Radiological Health (CDRH). He is responsible for providing leadership in the development, implementation, execution, management and direction of the Center's broad national and international premarket, postmarket, and compliance programs.

Prior to joining FDA, Dr. Maisel was Associate Professor of Medicine at Harvard Medical School with more than 15 years of clinical experience as a Board-certified cardiologist.

He is former Chair of the FDA Circulatory System Medical Device Advisory Committee and is a former member of the Center for Medicare and Medicaid Services Coverage Advisory Committee. Dr. Maisel received his undergraduate degree in biology from MIT, his medical degree from Cornell Medical College, and his Masters in Public Health from the Harvard School of Public Health. He has published more than 120 research manuscripts, book chapters, and scientific abstracts on regulatory science, device innovation, and medical device safety and effectiveness.

Nassir F. Marrouche, MD, FHRS

Nassir F. Marrouche, MD, FHRSDr. Nassir F. Marrouche is a globally renowned electrophysiologist and pioneer in the treatment of atrial fibrillation. He is a tenured Professor in the Division of Cardiovascular Medicine within the Department of Internal Medicine at Tulane University and is Director of the Tulane Heart & Vascular Institute.

He initiated a collaborative arrhythmia center that is bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists dedicated to working collaboratively to innovatively improve successful prediction, prevention and outcomes in the treatment of cardiovascular disease. He received his medical degree from the University of Heidelberg, Germany. He went on to complete his residency in Internal Medicine and Cardiology at Klinikum Coburg, teaching hospital of the University of Wurzburg, and completed clinical clerkships at the Cleveland Clinic Foundation, Harvard Medical School, University of Bristol, and University of Washington Medical Center. From there, he moved his training abroad where he completed Fellowships at the University of California, San Francisco, and the Cleveland Clinic Foundation. He is a Fellow of the American College of Cardiology and Heart Rhythm Society.

Dr. Marrouche has published his research findings in more than 200 peer-reviewed articles and prominent medical journals, including the New England Journal of Medicine, Circulation and Journal of the American Medical Association (JAMA).

Jamien McCullum

Jamien McCullumJamien McCullum is Co-Founder & CEO of Measure Labs, a team of machine learning scientists building correlates between the blood flow signal (PPG), physiological biomarkers, and outcomes data, with the goal to more accurately identify/predict high-risk patients using an optical signal. Measure Labs is a spin-out of the world's top-rated A.I. institute in the world, the Paul Allen Institute for Artificial Intelligence (Ai2).

Jamien started his career in technology investment banking for RBC, before joining early-stage venture capital fund New Cycle Capital investing in healthcare and fintech. He then co-founded Doctorbase a HIPAA secure physician-patient messaging platform used by over 25,000 healthcare providers and 10 million patients. Doctorbase was eventually acquired by Kareo Inc.

Jamien holds both an MA & BA from Stanford University and was one of the captains of the Stanford varsity football team.

David McManus, MD, MSci, FHRS

David McManus, MD, ScMDavid McManus, MD, ScM is a clinical and research cardiologist and cardiac electrophysiologist at the University of Massachusetts Chan Medical School (UMass Chan). He is also the Chair of the Department of Medicine at UMass Chan.

He served as the Department of Medicine's Vice Chair for Clinical Affairs and principal investigator for Rapid Acceleration of Diagnostics (RADx grant) where he brought innovative ideas and strategies for testing amidst the coronavirus pandemic. He also helped lead the UMass Memorial Health (UMMH) redeployment of health professionals during the coronavirus crisis.

Dr. McManus serves as Chief of the Section of Connected Cardiovascular Healthcare and Director of the Anticoagulation Service and Atrial Fibrillation Treatment Program at UMMH. He has led successful multi-site observational cohort studies (e.g., SAGE-AF) and clinical trials using point-of-care technologies (e.g., VITAL-AF, PULSEWATCH).

He has served in leadership roles on national research, quality, and patient advocacy committees for the Heart Rhythm Society, the American College of Cardiology, and the American Heart Association. For his work within the Cardiovascular Research Network, he received the HMO Research Network Early Career Investigator Award.

In 2012, he received a UMass Chan Clinical Scholar (K12) Award to understand mechanisms underlying cardiac remodeling and arrhythmia. Dr. McManus also received the Joan and Douglas Zipes Award for the most impactful manuscript published in HeartRhythm for his work describing his primary findings.

In 2017, he received two UMass Chan Science and Technology Awards focused on the development of mobile, digital, and electronic systems to enhance cardiovascular care: Data Driven Discovery in Healthcare (D3), with Mathew, Col; and the Center for Smart and Connected Society. He was selected as a Dr. Marcellette Williams Scholar in 2018.

In 2021, he was invested as the Richard M. Haidack Professor of Medicine, an endowed professorship, appointed founding director of the new Program in Digital Medicine and appointed President-Elect of the American Heart Association's Board of Directors.

Dr. McManus has published over 280 manuscripts, secured National Institutes of Health awards totaling over $130 million dollars as a primary investigator, and is the founding Editor-in-Chief of the Digital Cardiovascular Health Journal.

Darren McGuire, MD

Darren McGuire, MDDr. McGuire is a general cardiologist and clinical trialist with expertise in large-scale CV outcomes trial design and execution, and drug registration/regulation, with a focus on diabetes and cardiovascular disease. He has had leadership roles for numerous international cardiovascular clinical outcomes trials, including T2DM, obesity, and lipid trials.

Dr. McGuire is a previous member of the FDA Cardiovascular and Renal Drugs Advisory Committee and remains an FDA ad hoc consultant. He is Deputy Editor of Circulation, Senior Editor of Diabetes and Vascular Disease Research, co-editor of the textbook: Diabetes in Cardiovascular Disease: A Companion to Braunwald's Heart Disease and Chair of the AHA Diabetes Committee. Dr. McGuire has authored/co-authored over 400 peer-reviewed manuscripts, reviews, editorials and book chapters.

G. Stuart Mendenhall, MD, FHRS

G. Stuart Mendenhall, MDG. Stuart Mendenhall, MD, FHRS, practices at Scripps Memorial Hospital - La Jolla in clinical cardiac electrophysiology. He graduated with degrees in Chemistry and Physics from Harvard and continued on to the Harvard-MIT Health Science and Technology MD program where he completed an HHMI fellowship prior to cardiology and electrophysiology training.

His background in computer science has been applicable to both his research focusing on making cardiac devices "smarter," and entrepreneurial activity as the co-founder and chief medical officer for Everbeat, maker of an ECG ring and analytics platform. Outside of the clinic he is an avid pilot and classical pianist.

Rohit Mehta, MD, FACC, FHRS

Rohit Mehta, M.D., FACC, FHRSRohit Mehta, M.D., FACC, FHRS is a cardiac electrophysiologist at the Sanger Heart and Vascular Institute in Charlotte, NC. He earned his undergraduate degree at Duke University in Durham, NC. He then returned home to Arkansas where he completed his medical degree at the University of Arkansas for Medical Sciences in Little Rock. He then went on to Columbus, OH and The Ohio State University where he trained in Internal Medicine, Cardiovascular Diseases, and then in Cardiac Electrophysiology.

He is board certified in Cardiac Electrophysiology and Cardiovascular Diseases. He joined Sanger Heart and Vascular Institute in 2008 with expertise in laser lead extraction (removal), complex cardiac device implantation, complex cardiac ablation, and large-scale data management. He served as medical director for cardiac electrophysiology from 2012-2016 and as director of the cardiac device clinic from 2010-2022.

He serves on the board of directors for the Omar Carter Foundation- serving as co-chairman since its inception in 2014. His clinical passion has been and remains sudden cardiac arrest- with a focus on innovative care delivery, risk prediction and CPR awareness.

Michael J. Mirro MD, FACC, FHRS, FACP

HRX 2022 Speaker: Michael MirroChief Academic Research Officer: Parkview Health
Clinical Professor of Medicine
Adjunct Professor of Bioinformatics Indiana University

Michael J. Mirro, MD, received his medical degree from Indiana University School of Medicine.  He completed his Internal Medicine Residency, Cardiology Fellowship and EP/Research Fellowship at Indiana University Medical Center. Dr Mirro is board certified in internal medicine, cardiovascular disease, clinical cardiac electrophysiology, and geriatrics. He is a Certified Cardiac Device Specialist (IHRBE-CCDS).

The past 35 years, Dr Mirro has focused his clinical work on implantation of CIEDs and clinical investigation into new and advanced technology to enhance CIED function. This work has led to a focused effort to improve remote patient monitoring and improving methods to transmit remotely recorded CIED data from patient specific device back to the patient electronically.  Dr Mirro participated in the IHE-IDCO work group that developed the data standard to allow electronic transmission of structured data from CIED to EHR/PHR. He testified before the Senate HELP Committee 2015 on Interoperability representing the ACC. Currently, he serves on the HRS Interoperability work group.

 In addition to his clinical work, Dr Mirro has been an advocate for reimbursement of cardiac technologies, having served as a member of the Board of Trustees of the American College of Cardiology (ACC) from 2003 to 2009 and having served as the co-chair of the ACC Advocacy Committee from 2002 to 2004. Trustee Indiana University 2014-2023 (Chair-2018-2022).

Suneet Mittal, MD, FHRS

Suneet Mittal, MD, FHRSDr. Mittal earned his BA and MD degrees from Boston University as part of a combined 6-year BA-MD program. He did an internship and residency in Internal Medicine as well as a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. He then completed a fellowship in Clinical Cardiac Electrophysiology at the New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Mittal is board certified in Cardiovascular Disease and Clinical Cardiac Electrophysiology.

He is currently the Director of the Electrophysiology Laboratory and Associate Chief of Cardiology at The Valley Hospital in Ridgewood, New Jersey.

Dr. Mittal's active research interests include the evaluation and management of patients with atrial fibrillation, the role of the left atrial appendage in patients with persistent atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias, and overcoming barriers to remote patient monitoring.

He is a member of the Heart Rhythm Society's Board of Trustees. He is currently Associate Editor of the newly launched Cardiovascular Digital Health Journal and an Editorial Board member of Circulation: Arrhythmia & Electrophysiology, Journal of American College of Cardiology: Electrophysiology, Heart Rhythm, Heart Rhythm O2 and Journal of Interventional Cardiovascular Electrophysiology.

Siddhartha Mukherjee, MD, DPhil

Siddhartha Mukherjee, MD, D.PhilAfter completing school education in India, Mukherjee studied biology at Stanford University, obtained a D.Phil. from University of Oxford as a Rhodes Scholar, and an MD from Harvard University. He joined New York–Presbyterian Hospital / Columbia University Medical Center in New York City in 2009. As of 2018, he is an Associate Professor of Medicine in the Division of Hematology and Oncology.

Featured in the Time 100 list of most influential people, Mukherjee writes for The New Yorker and is a columnist in The New York Times. He is described as part of a select group of doctor-writers (such as Oliver Sacks and Atul Gawande) who have "transformed the public discourse on human health" and allowed a generation of readers a rare and intimate glimpse into the life of science and medicine.] His research concerns the physiology of cancer cells, immunological therapy for blood cancers, and the discovery of bone- and cartilage-forming stem cells in the vertebrate skeleton.

The Government of India conferred on him its fourth highest civilian award, the Padma Shri, in 2014.

Shawn Murphy MD, PhD

Paul GrandDr. Murphy is the Chief Research Information Officer at Mass General Brigham, is a Professor of Neurology and Biomedical Informatics at Harvard Medical School and serves as Co-Director of the Center for Innovation in Digital Healthcare at the Massachusetts General Hospital. He received his BS in Chemistry from the University of Notre Dame, and his Ph.D. in Pharmacology and Physiology and MD from the University of Chicago. Dr. Murphy's research interests include the creation of query methods for healthcare data that enable them to be directly used by scientists even when the data is extremely large.

Dr. Murphy was an inventor of Informatics for Integrating Biology and the Bedside (i2b2), a high impact and widely accepted open-source project that focuses on the integration of highly diverse phenotypic, imaging, and genomic data such that new discoveries can be visualized and produced from secondary use of routinely collected healthcare data and be applied to new methods of providing clinical decision and trial support in a learning healthcare system.

Sanjiv Narayan, MD, PhD, FHRS

Sanjiv Narayan, MDDr. Narayan is Professor of Medicine and Co-Director of the Arrhythmia Center at Stanford University. Dr. Narayan works at the intersection of cardiology, bioengineering and artificial intelligence (AI) to improve patient care. Dr. Narayan is trained in computer science, artificial intelligence and data science as well as cardiac electrophysiology. His Computational Arrhythmia Research Laboratory has been funded continuously since 2001 by the U.S. National Institutes of Health. He has studied many causes of heart rhythm disorders, and his lab pioneered computerized mapping to tailor ablation for atrial fibrillation.

Dr. Narayan has published over 300 peer-reviewed articles, reviews and book chapters. He trained in medicine and software engineering in Birmingham UK, UCLA, Harvard/Mount Auburn Hospital and Washington University in St. Louis. Dr. Narayan received the 2022 Distinguished Scientist award of the Heart Rhythm Society. His trainees have won research prizes and grants each year since 2003. He has been recognized "Top Doctor" by Castle Connolly.

Ken Nelson

KennethNelsonOver the past 10 years, Ken has led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, playing a significant role in building the teams, cultures, and infrastructures for 3 of the top 4 market share players in cardiac digital health and remote patient monitoring, including #1 (BioTelemetry as VP of Sales), #2 (iRhythm as VP of Sales & Marketing), and #4 (Bardy Diagnostics as Chief Commercial Officer).

Overall, he is a 20 year digital health, medical device, and remote patient monitoring executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to a #1 market share leading medium sized company (Biotelemetry, acquisition by Philips for $2.8 Billion announced in December '20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was just acquired by HillRom (Bardy Diagnostics) in August 2021 for what will end up being $400M+ after milestone payments.

Ken earned a B.A. in Economics from Vanderbilt University and resides in Dallas, TX with his wife and 3 children.

Justin Norden, MD, MBA, MPhil

Justin NordenJustin Norden is a Partner at GSR Ventures ($3.5B AUM), where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health. As an academic he is an award winning machine learning and bioinformatics researcher and directs the digital future of health care course at Stanford. Finally, Justin is a former professional athlete and 3x world champion in ultimate frisbee.

Justin received his MD from Stanford University School of Medicine, MBA from the Stanford Graduate School of Business, M.Phil in Computational Biology from the University of Cambridge, and BA in Computer Science from Carleton College.

Matt O'Neal

Matt O'NealCo-Founder and CEO of PrepMD RMS

Matt has over 40 years of leadership experience in the medical device industry and played a key role in the commercial launch of breakthrough technologies, including the first implantable defibrillator (ICD), the first transvenous ICD therapies and Anti-Tachycardia (ATP) device applications. As a Vice President of Sales for Boston Scientific, Matt drove the development of new innovative simulation training programs that became a staple within the company and across the industry, that has fostered clinical excellence.

Matt co-founded PrepMD in 2009 and in 2011 was awarded the Most Innovative Business Plan of the Year by the Small Business Administration (SBA). In 2013 he initiated a contract staffing organization to support the service demands being placed on device clinics around the country. In 2015 Matt co-founded PrepMD RMS which provides remote monitoring solutions, both service and SaaS based options, enabling versatility and workflow optimization.

Matt also served on the Biomedical Advisory Board at the Georgia Institute of Technology and is a graduate of the University of Massachusetts.

Sherry Pagoto, PhD

Sherry Pagoto, PhDDr. Pagoto is a licensed clinical psychologist, professor, and digital health researcher. She is a Professor in the Department of Allied Health Sciences at the University of Connecticut, Director of the UConn Center for mHealth and Social Media, and Past-President of the Society of Behavioral Medicine. Her research focuses on leveraging mobile technology and social media in the development and delivery of behavioral interventions for cardiovascular disease prevention.

She has had federal funding for her research for 19 consecutive years, has published 225 papers in peer-reviewed journals on these topics, and was the 2014 recipient of the Obesity Society Pioneer in mHealth/eHealth.

Rod S. Passman, MD, FHRS

Rod S. Passman, MD, FHRSRod S. Passman, MD, FHRS is the Jules J Reingold Professor of Electrophysiology and Professor of Medicine and Preventive Medicine at Northwestern University Feinberg School of Medicine.

He is the founder and director of the Northwestern University Center for Arrhythmia Research and his research focused on AF and digital health has been funded by AHA, NIH, and industry.

Jessica Paulsen

Jessica PaulsenJessica Paulsen is the Director of the Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices in the Office of Cardiovascular Devices in FDA's Center for Devices and Radiological Health (CDRH). She also leads the Digital Health Focal Point Program, which aims to promote communication, collaboration, and consistency in Digital Health product reviews across CDRH. She earned her B.E. in Biomedical Engineering and Engineering Management from Vanderbilt University.

Jeanne E. Poole, MD, FHRS

Jeanne PooleDr. Poole is a Professor of Medicine at the University of Washington in Seattle. She obtained her MD from the University of Washington, as well as Cardiology and Electrophysiology fellowship training. She is a UW faculty Electrophysiologist and until recently had been the EP Section Head for over 20 years and was also the EP Fellowship Director for 14 of those years. She has focused her clinical research career on the prevention of sudden cardiac death with implantable defibrillators, participating as a P.I or co-P.I in many landmark clinical trials, including the SCD-HeFT study. Other research interests include new implantable device technology, cardiac resynchronization therapy, and management of atrial fibrillation.

She was a Co-PI on the recent CABANA trial, leading the arrhythmia core lab. She has participated and/or led numerous clinical trial committees, such as event adjudication and data safety and monitoring, and has been a speaker, moderator and course director for both national and international meetings. Dr. Poole is a passionate supporter for Women in EP, participating and/or leading several Women in EP organizations. She champions enhanced enrollment of women and racial/ethnic minorities into clinical trials, having co-authored multiple publications.

Dr. Poole has served on many HRS committees and most recently, the Board of Trustees. In 2021, she was honored with the Wilton Wells Webster Lectureship Award for innovation in the advancement of patient care. She is currently the Editor-in-Chief of the Heart Rhythm O2 Journal.

Satish R. Raj, MD, MS, FHRS

Satish R. Raj, MDSatish R. Raj is a Professor of Cardiac Sciences and the Section Chief of the Cardiac Arrhythmia Group at the University of Calgary in Canada. He also serves as the Director of Education at the Libin Cardiovascular Institute in the University of Calgary's Cumming School of Medicine. He is currently Co-Chair of the Heart Rhythm Society Writing Committee on Remote Monitoring.

Pranav Rajpurkar, PhD

Pranav Rajpurkar, PhDPranav Rajpurkar is an Assistant Professor at Harvard Medical School leading a research lab working on developing artificial intelligence technologies for medical applications. His lab has developed label-efficient deep learning algorithms that can read medical images at the level of experts, built large-scale open medical datasets, and demonstrated the effects of AI on medical decision making.

Prof. Rajpurkar co-hosts The AI Health Podcast and co-edits the Doctor Penguin AI Health Newsletter. He instructed the Coursera course series on AI for Medicine, and leads the joint Harvard-Stanford Medical AI Bootcamp Program. Previously, Prof. Rajpurkar received his B.S., M.S., and Ph.D. degrees, all in Computer Science from Stanford University.

Noemi Ray


Recognized as one of the Top 25 Women Leaders in Medical Devices for 2021 and 2022, Noemi Ray leads PaceMate™ as Vice President of Product Operations. Ray’s broad industry experience as a registered nurse, pharmacy manager, and cardiac device clinical specialist, as well as her hands-on sales and technical support for cardiovascular devices in the field, has prepared her to lead PaceMate™ with diligence and excellence.

While serving as a cardiovascular rhythm management representative with Medtronic and St. Jude Medical, Ray recognized a need for full-service remote monitoring. Combining her career expertise with her passion for making a difference, she and PaceMate co-founder Jason Hale hatched a plan that would become PaceMate.

Today, Ray serves as pioneering leadership for PaceMateLIVE, the customized cardiac implantable electronic device (CIED) monitoring Software+Service solution produced by PaceMate™. Her goal is to add a unique level of compassion to the brand, setting a standard of equality in the medical workspace and causing it to shine through in the company’s customer service, mission, and core values. 

Ray is a graduate of Louisiana State University-Alexandria with a Bachelor of Science degree with a major in Nursing and a Bachelor of Arts degree from Northwestern State University.

Vivek Reddy, MD

Vivek Reddy, MDVivek Y. Reddy, MD is Director of Electrophysiology for the Mount Sinai Health System, and The Helmsley Trust Professor of Medicine in Cardiac Electrophysiology at the Icahn School of Medicine at Mount Sinai.

He is also a Visiting Professor of Cardiology at Homolka Hospital in Prague, Czech Republic, where he has had an appointment since 2001.

David Rhew, MD

David Rhew HRXDr. David C. Rhew is the Global Chief Medical Officer (CMO) & VP of Healthcare for Microsoft. He is Adjunct Professor at Stanford University; holds six U.S. technology patents that enable authoring, mapping, and integration of clinical decision support into electronic health records; and has been recognized as one of the 100 most influential persons in healthcare by Modern Healthcare.

Dr. Rhew received his Bachelors of Science degrees in computer science and cellular molecular biology from University of Michigan. He received his MD degree from Northwestern University and completed internal medicine residency at Cedars-Sinai Medical Center. He completed fellowships in health services research at Cedars-Sinai and infectious diseases at the University of California, Los Angeles.

He has served as CMO and VP for Samsung; SVP and CMO at Zynx Health Incorporated; clinician/researcher at the VA Greater Los Angeles Healthcare System and RAND; and Associate Clinical Professor of Medicine at UCLA. Dr. Rhew has served on the National Quality Forum’s Executive Committee for Consensus Standards and Approval, Chaired the Consumer Technology Association Health Technology Board, and sits on the Governing Committee for NESTcc (National Evaluation System for health Technology coordinating center), the medical device advisory group for the FDA, CMS, and NIH.

Fátima Rodriguez, MD, MPH

Fátima Rodriguez, MD, MPHFátima Rodriguez, MD, MPH is an Assistant Professor in the Division of Cardiovascular Medicine at Stanford University and a noninvasive and preventive cardiologist. Dr. Rodriguez earned her medical degree from Harvard Medical School and her MPH from the Harvard School of Public Health as Zuckerman Fellow at the Harvard Kennedy School's Center for Public Leadership. She then completed internal medicine residency at Brigham and Women's Hospital. Dr. Rodriguez arrived at Stanford University in 2014, where she completed a cardiovascular medicine fellowship and served as Chief Fellow. She currently serves as the Affinity Lead of Preventive Cardiology at Stanford University.

Dr. Rodriguez's research interests include a range of issues relating to racial and ethnic disparities in guideline adherence, cardiovascular disease prevention, Hispanic cardiovascular health, advancing scientific workforce diversity, and leveraging technology to improve the care of diverse patients. She has authored over 140 peer-reviewed publications on these topics and recently received the American College of Cardiology's Douglas P. Zipes Distinguished Young Scientist Award. She has also been a two-time winner of Stanford University's Alderman Award for Excellence in Clinical Research and the Department of Medicine Chair Diversity Investigator Award. Her work is funded by the National Heart, Lung, and Blood Institute and the American Heart Association. Dr. Rodriguez is a Fellow of the American College of Cardiology and the American Heart Association and she is the Co-Chair of the National Minority Cardiovascular Alliance. She serves as an Associate Editor for the New England Journal of Medicine Journal Watch Cardiology and is a member of the American Heart Association's Science Advisory and Coordinating Committee (SACC).

Arnaud Rosier MD, PhD

Arnaud Rosier MD, PhDArnaud Rosier MD, PhD is a cardiac electrophysiologist which a focus in the field on digital health. More specifically, his field of work include knowledge engineering in life science and the development of innovative technologies (including Software as a Medical Device) used to transform the burden of remote monitoring in cardiology into an opportunity for research, through automation of human tasks.

Arnaud is the founder and CEO of Implicity, a global clinical algorithm company providing software to providers in order to scale remote cardiac monitoring of patients across the world. Focus includes cardiac electronic implants and heart failure. Implicity is the first company to have access to the health data hub (4 millions patients in EU) in order to provide predictive tools for heart failure management.

Andrea M. Russo, MD, FACC, FHRS, FAHA

Andrea M Russo, MD, FACC, FHRS, FAHADr. Russo is currently Professor of Medicine at Cooper Medical School of Rowan University, Academic Chief, Division of Cardiology, Director of Electrophysiology and Arrhythmia Services and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey.

She was Past President of the Heart Rhythm Society (HRS) and has volunteered on multiple HRS committees. In addition, she has authored multiple manuscripts on a variety of arrhythmia and device topics and has been co-chair or member of various writing groups, including guideline, consensus and appropriate use documents. Areas of special interest include sex differences in arrhythmias, implantable cardioverter defibrillators, atrial fibrillation therapy, and the role of digital health in arrhythmia management.

Amber Seiler, NP​, FHRS, CEPS, CCDS

Amber Seiler, NP​, FHRS, CEPS, CCDSFor the last 2 decades, Amber has been instrumental in creating and optimizing device clinic across the country. Initially through ConeHealth in Greensboro, NC and more recently through founding CV Remote Solutions. She is passionate about device care and optimizing workflows to allow all patients and clinics to take advantage of the technology available.

She is a member of several HRS committees and is a Fellow of the Heart Rhythm Society. In addition to device management, Amber is also involved in helping to create AF centers of excellence across the country. Her CCDS and CEPS certifications speak to her commitment to patient care and meeting the highest bar in the heart rhythm space.

Bimal R. Shah, MD, MBA

Bimal R. Shah, MD, MBABimal Shah is the chief operating officer of Homeward, a company focused on improving access to high-quality, affordable comprehensive care in rural communities. Bimal is part of the founding team of Homeward and has a deep passion for increasing access to comprehensive, value-based care in rural markets.

Bimal is also a practicing cardiologist and has experiences over the past 20 years of providing care in underserved communities. Previously, while at Duke University, he investigated issues and trends in the quality of care and outcomes in patients with cardiovascular disease. His work also focused on developing projects on cost-effective analysis for medical interventions, use of remote technologies for chronic disease management and risk stratification, and drivers utilization of care across the United States.

Bimal is a seasoned health tech executive, mentor, investor and board member. Previously, Bimal served as chief medical officer at Livongo where he led the clinical development of their cardiovascular program.

Bimal completed his Bachelor of Arts in Economics and Chemistry at the University of North Carolina at Chapel Hill. He went on to get his MBA in Health Sector Management from the Duke University Fuqua School of Business and his MD from the Duke University School of Medicine.

Jennifer N. Avari Silva, MD, FHRS, CEPS-P

Jennifer N. Avari Silva, MD, FHRS, CEPS-PJennifer Silva is Director of Pediatric Electrophysiology and a Professor of Pediatrics and Biomedical Engineering at Washington University School of Medicine/St. Louis Children’s Hospital, and serves as the Faculty Fellow in Entrepreneurship for Washington University SOM. She serves on committees within the Heart Rhythm Society (Chair, Women in Electrophysiology; VChair, Growth and Leadership Opportunity for Women in Electrophysiology; Production Team, HRX; Member, Membership Committee) and Pediatric and Congenital Electrophysiology Society (Vice President of Finance) and serves on the NIH-SBIR study section for Cardiovascular Innovation. She is a Senior Member of the National Academy of Inventors and also serves on the Editorial Board of Circulation: Arrhythmia and Electrophysiology, Heart Rhythm O2, and Cardiovascular Digital Health journals.

The scope of her research has been in innovation and emerging technologies with on developing and identifying clinical applications of new and emerging technologies within cardiac electrophysiology, particularly in the scope of wearable and advanced wearable technologies, including the extended realities.

Jennifer is the co-inventor and co-founder of SentiAR, Inc, a venture-backed software device spinout from Washington University which is developing the first mixed reality platform to display intraprocedural 3-dimensional holographic visualization of a patient’s cardiac anatomy with real time catheter locations with submission to the FDA in 2019. In 2018, the company received a NIH-SBIR award for $2.2M and in 2021 closed a $5.1M Series A Round. Most recently, she has co-founded a second company, Excera, Inc. which aims to improve outcomes for ultrasound-guided minimally invasive procedures.

Jag Singh, MD, PhD, FHRS

Jag Singh, MD, PhD, FHRSJag Singh is a Professor of Medicine at Harvard Medical School. He is the former Clinical Director of the Cardiology Division and the Roman W. DeSanctis Endowed Chair in Cardiology at Mass General Hospital. Dr. Singh completed his internal medicine residency, cardiology and cardiac electrophysiology fellowships at Mass General Hospital. He completed a doctorate from Oxford University, a Master of science in clinical investigation from MIT-Harvard and a research fellowship at the Framingham Heart Study.

Dr. Singh has over 350 peer reviewed publications and has given over 450 invited lectures at national and international conferences. He is the former Deputy Editor of the Journal of American College of Cardiology: Clinical EP and Editor-in-chief of the Current Treatment Options in Cardiovascular Medicine.

Dr. Singh's is currently the national & global principal investigator on 7 ongoing multi-center clinical trials in device therapy, sensor strategies and artificial intelligence for heart failure and atrial fibrillation. Much of his current efforts are focused on healthcare redesign, digital health, and medical device innovations.

He is the author of the forthcoming book Sensored-Reinventing Healthcare.

David Slotwiner, MD, FHRS

David Slotwiner, MD, FHRSAs Chief of the Division of Cardiology at New York Presbyterian Queens and Assistant Professor of Medicine with an appointment in Population Health at Weill Cornell Medicine, Dr. David Slotwiner has devoted his career to patient care, mentoring trainees and addressing challenges in every day clinical medicine by pursuing health policy and technological solutions.

Since 2005 he has helped lead a multi-stakeholder collaboration to develop a standard lexicon of data elements for managing data generated by implantable pacemakers and defibrillators. Under the auspices of the American College of Cardiology and the Heart Rhythm Society, all manufacturers of these devices have collaborated to create this lexicon which has been balloted and approved by the Institute of Electrical and Electronics Engineers, the standards development organization governing data from electrocardiograms and implantable cardiac rhythm management devices.

As a member of the U.S. Food and Drug Administration's Cardiovascular Advisory Panel, he has had the opportunity to advise the Agency on numerous novel devices as well as develop new strategies to conduct post-approval surveillance of these devices. He has participated in authoring several practice guidelines and expert consensus statements on topics including management of atrial fibrillation, management of patients with ventricular arrhythmias, remote monitoring of implantable pacemakers and defibrillators, and indications for physiologic pacing using newer techniques such as His-bundle pacing and cardiac resynchronization therapy.

Recently he served on the Board of Trustees of the Heart Rhythm Society, and he is a Section Editor of the Heart Rhythm Society's new Cardiovascular Digital Health Journal.

Richard Strobridge

Richard StrobridgeRichard is an award-winning digital health CEO with proven expertise in tech start-ups in the healthcare and clinical research sectors. Richard invented the first wireless blood glucose meter, co-founded one of the first tele-surgery companies and has three digital health exits. Richard's awards include the New Product Innovation Award (2x), Best Practices Award, High Tech America Award, Wireless Innovation & Excellence Award, eHealthcare Leadership Award and Digital Health Global 100 Award. Richard is the CEO of Rx.Health, an innovative digital health unification, automation, and engagement platform company.

Kenneth Stein, MD, FACC

Kenneth Stein, MD, FACCDr. Ken Stein is currently Senior Vice President and Chief Medical Officer for Rhythm Management at Boston Scientific. Ken is a Phi Beta Kappa graduate of Harvard College (Economics), and an Alpha Omega Alpha graduate of New York University School of Medicine. He completed his medical internship and residency at The New York-Presbyterian Hospital/Weill Cornell Medical Center, where he also completed his cardiology and cardiac electrophysiology fellowships. Prior to joining Boston Scientific in 2009, Dr. Stein held the position of Associate Director of Clinical Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at Cornell University where he was widely published, authoring over 150 peer-reviewed scientific publications in the areas of cardiac electrophysiology with special interest in cardiac resynchronization therapy and risk stratification for sudden cardiac arrest. Dr. Stein currently oversees clinical trials, medical safety, and medical affairs for Boston Scientific’s Rhythm Management divisions as well as the company's global clinical trials operations.

Since 2013, Dr. Stein has served on the board of Childrens HeartLink, a registered 501c(3) nonprofit organization that trains and mentors medical teams in underserved parts of the world to diagnose and treat children with heart disease. Founded in 1969, Children's HeartLink currently supports partner hospitals in Brazil, China, India, Malaysia, Ukraine and Vietnam. 

Kamala P. Tamirisa, MD, FHRS

Kamala Tamirisa, MDr. Tamirisa is a clinical cardiac Electrophysiologist with Texas Cardiac Arrhythmia, one of the largest EP only groups, active in clinical research and teaching/training fellows, in Dallas. Clinical EP physician with interest in closing gaps in healthcare delivery by effectively integrating AI & customizing care using precision medicine principles.

Contributed scientific review articles on AF management & differences, commentaries on how to tackle sex & racial ethnic disparities in the field of EP (AF & beyond), & worked/led community programs to understand & help close these gaps (Healthcare system, AHA, Voluntary etc). Chair of HRS DEI council 2022-2023.

Kevin Thomas, MD, FHRS

Kevin Thomas, MDDr. Thomas is an Associate Professor of Medicine with Tenure in the Department of Medicine, Division of Cardiovascular disease, Section of Clinical Cardiac Electrophysiology at Duke University Medical Center. He maintains multiple leadership positions across Duke Health and the School of Medicine including: Vice Dean for Diversity Equity and Inclusion, Assistant Dean for Underrepresented Faculty Development, the Director of Faculty Diversity and Health Disparities Research at the Duke Clinical Research Institute (DCRI), Associate Director of the Duke CTSA TL-1 scholars program, Co-founder and Co-director of the Duke Health Disparities Research Curriculum, and Co-director of the Research Education and Training core of the Duke REACH EQUITY Center of Excellence in health disparities research. He has over 80 peer reviewed publications and has received research funding from NIH/AHA/ and PCORI.

He is a member of the National Heart, Lung, and Blood Institute’s advisory council. He has a large clinical practice and specializes in the management of complex arrhythmias.

Eric Topol, MD

Eric Topol, MDEric Topol is Professor, Molecular Medicine, and Executive Vice-President of Scripps Research, and Founder and Director of its Scripps Research Translational Institute. He has published over 1200 peer-reviewed articles, with more than 300,000 citations, elected to the National Academy of Medicine, and is one of the top 10 most cited researchers in medicine. His principal scientific focus has been on the use of genomic and digital data, along with artificial intelligence, to individualize medicine. He is a practicing cardiologist.

In 2016, Topol was awarded a $207M grant from the NIH to lead a significant part of the Precision Medicine (All of Us) Initiative, a prospective research program enrolling 1 million diverse participants in the US. This is in addition to his role as principal investigator for a flagship $35M NIH CTSA grant to promote innovation in medicine. Prior to coming to Scripps in 2007, he led the Cleveland Clinic to become the #1 center for heart care and was the founder of a new medical school there. Topol was commissioned by the UK 2018-2019 to lead planning for the National Health Service’s integration of AI and new technologies. He has published 3 bestseller books on the future of medicine: The Creative Destruction of Medicine and The Patient Will See You Now and latest Deep Medicine: How Artificial Intelligence Can Make Healthcare Human Again.

Anne Thorndike, MD, MPH

Anne Thorndike, MD, MPHAnne Thorndike, MD, MPH is Associate Professor of Medicine at Harvard Medical School and an internist at Massachusetts General Hospital (MGH). Dr. Thorndike is the director of the Cardiac Lifestyle Program at the MGH Cardiovascular Disease Prevention Center. Her clinical and research interests are the prevention and treatment of obesity and cardiometabolic disease through lifestyle modification and the impact of social determinants on dietary quality and health.

Funded by the NIH and foundations, her research has tested interventions using behavioral economics strategies to improve dietary intake and health outcomes in worksite and community-based settings. She is a longstanding member of the Nutrition Committee of the American Heart Association and recently served as chair from 2020-2022.

Mintu Turakhia, MD, MS, FHRS

Mintu Turakhia, MD, MS, FHRSDr. Turakhia is an internationally recognized cardiac electrophysiologist, researcher, executive, and leader in digital health and heart rhythm care. Trained in computer science, medicine, biostatistics, and research, he brings over 20 years of experience in patient care, outcomes research and trials, data science and artificial intelligence, medical device regulation, and the creation and commercialization of digital health products.

At Stanford, he was the Co-Founder and Director of the Stanford Center for Digital Health, where he led a large multidisciplinary research program in heart rhythm disorders, real-world evidence, clinical trials, and digital health. He has led several large-scale trials of digital health tools and wearables for heart disease, including as co-principal investigator of the landmark Apple Heart Study, enrolling over 400,000 participants, and published in the New England Journal of Medicine. For 14 years, he served as Chief of Cardiac Electrophysiology at the VA Palo Alto Health Care System, where he developed a best-in-class, high volume arrhythmia care program and where he continues to treat patients with arrhythmia procedures. 

In academic and industry roles, he has led teams to build and commercialize software-enabled disease management and remote patient monitoring programs for heart disease with several recent exits. An elected member of the American Society of Clinical Investigation, Dr. Turakhia has authored over 300 publications and has received over $40 million in research funding. Over the last 20 years, he has had several dozen leadership and clinical practice guideline author roles in the Heart Rhythm Society, American Heart Association, American College of Cardiology, and European Society of Cardiology. 

Dr. Turakhia completed his bachelor’s degree at the University of California (UC) Berkeley, MD and master’s degrees at UCSF, and clinical training at Harvard’s Brigham & Women’s Hospital and UCSF.

Manish Wadhwa, MD, FHRS

Manish Wadhwa, MD, FHRSAs a co-founder of Geneva Health Solutions, Dr. Wadhwa joined our family of companies in March 2019 as part of the Geneva Health Solutions acquisition. He is an actively practicing, board-certified cardiologist and cardiac electrophysiologist. After interviewing for medical school at the age of 16, Dr. Wadhwa enrolled in Penn State University's Thomas Jefferson Medical College Six Year BSc-MD program. Upon completion, Dr. Wadhwa trained in internal medicine and general cardiology at Thomas Jefferson University Hospital in Philadelphia, PA. He completed his cardiology training with two years of advanced fellowship in cardiac electrophysiology at the University of California at San Diego.

Dr. Wadhwa has expertise in both implanted device management as well as invasive and non-invasive treatments of arrhythmias. He has been serving the San Diego community in private practice since 2000. Dr. Wadhwa has served on the physician advisory boards of Medtronic, Boston Scientific, Biotronik, St. Jude Medical and Sanofi-Aventis, and is a fellow of the Heart Rhythm Society (FHRS) and American College of Cardiology (FACC). Dr. Wadhwa has authored numerous medical papers and lectures on clinical issues in cardiac electrophysiology.

Matt Wilson

Matt WilsonMatt is currently the Vice President of Operations at PrepMD RMS. He joined the company in 2018 with the goal of improving patient care and providing solutions for cardiac device clinics through training, staffing and remote monitoring services.

Prior to joining PrepMD RMS, Matt spent over 10 years with Boston Scientific in the Cardiac Rhythm Management (CRM) division. As an IBHRE®-Certified Cardiac Device Specialist (CCDS) senior sales representative, he managed a successful sales team in the New York City area. During his tenure at Boston Scientific, Matt witnessed the unique challenges faced by cardiac device clinics and is now providing solutions for many of those same partners.

A former U.S. Army Ranger and Infantry Captain, Matt's passion lies in developing effective teams to tackle complex healthcare challenges. He resides in Hingham, MA with his wife and their three children.

Clyde W. Yancy, MD, MSc

Clyde W. Yancy, MD, MScVice Dean for Diversity and Inclusion, chief of Cardiology  Medicine, and Magerstadt Endowed Professor of  Internal Medicine/Cardiology at Northwestern  University Feinberg School of Medicine, Chicago, IL. He serves as Deputy Editor for JAMA Cardiology. He is a former President of the American Heart Association.

His government service includes leadership positions in the NIH, NHLBI, PCORI, FDA and Department of Health and Human Services. His research considers heart failure, heart transplantation, outcomes sciences and health disparities. He has published more than 600 peer-reviewed manuscripts, and received numerous awards as a top physician, teacher and mentor in cardiology.

He holds elected membership in the National Academy of Medicine and the American Association of Physicians.